In 2003 Toronto Canada experienced a severe acute respiratory syndrome (SARS) that was first discovered with the return of Kwan Sui-chu from Hong Kong. This disease caused a major strain on the Toronto public heath (TPH) and hospital system. The outbreak of the SARS was quick and the World Health Organization (WHO) delayed response to the outbreak gave way to its spread from Hong Kong. With the outbreak of SARS it created a panic in Toronto and they were put on the World Health Organization alert list for potential exposure to condition.
The following case study is of a 37-year old Hispanic male weighing 145 lbs and 70 inches tall found unconscious by his girlfriend. According to her he was unconscious for about 15 hours and she was concerned because he would not wake or respond and was breathing shallow and slow. She then called 9-1-1. The patient entered the ER by emergency vehicle and on my initial assessment Pt had an altered mental status, was very unresponsive showing symptoms of a possible drug overdose. The girlfriend told the physician the Pt had taken 75 mg of methadone and an unknown amount of Xanex and other amounts of Benzodiazepines. On assessment, the doctor noticed his altered mental status and unconscious status. He had a gag
Because of the uncertainties and evolving nature of infectious diseases, outbreaks can cause substantial fear in communities and in the general public. Such is the case with the severe acute respiratory syndrome (SARS) epidemic in 2003. It was the first serious infectious disease of the twenty first century and questions about its origin and treatment greatly outnumbered the answers.
Many people take breathing for granted, some never give it a second thought until a problem presents itself. Respiratory diseases affect millions of Americans as well as people from all over the world. Anyone can suffer from these disorders to include men, women, and children, with conditions ranging from mild, moderate, to chronic in nature. This paper will focus on one of the many respiratory disease called mycobacterium tuberculosis; more commonly referred to as TB.
At the first possible outbreak of SARS, the nurse will need to follow protocol. The initiation of the protocol begins with an assessment of the patient. A doctor will determine if the patient is possibly infected with SARS by following the physical and epidemiologic criteria. The Center of Disease Control and Prevention mandates reporting to the all cases where the patient has pneumonia of an unknown origin, and could have recently been exposed of the SARS virus [ (Center of Disease Control, 2005) ]. Once the report has been made the community health nurse should have all hospitalized patients with respiratory symptoms questioned on their recent history and possibilities of contact with the virus. Next, the community health nurse needs to educate staff and the community about possible ways to contract SARS, and encourage behaviors such as, frequent hand washing, covering their nose and mouth while coughing or sneezing, and using and properly disposing of tissues for respiratory secretions. [ (Center of Disease Control, 2005) ] Once health care members and the public are educated on the route of transmission they can prevent being exposed. Confirmed infected patients would be transferred to Seattle, where they can be in isolation rooms, patients can be more critically monitored, and research centers can be of benefit to
1. A physician is called to the intensive care unit to provide care for a patient who received second- and third-degree burns over 50 percent of his body due to a chemical fire. The patient is in respiratory distress and is suffering from severe dehydration. The physician provides support for two hours. Later that day the physician returns and provides an additional hour of critical care support to the patient.
The American Association for Respiratory Care is a non-profit organization which provides numerous resources for registered respiratory therapists all over the United States. Membership through the AARC renders an abundance of incentives such as professional development, respiratory care education, social networking opportunities, continuing education programs and much more. The American Association for Respiratory Care truly believes in the cause of respiratory therapy and in the rights of their patients to receive competent respiratory care. Their advocacy team works with local, state and federal governments concerning public policies that affect their patients as well as their profession.
pandemics: the Spanish flu of 1918, the Asian flu, the Hong Kong flu and the terror and
Acute respiratory distress syndrome (ARDS) is characterized by ventilation and perfusion mismatching that leads to hypoxic respiratory failure. Ashbaugh and colleagues first defined it in 1967 when they described 12 patients with severe acute respiratory failure (Ferguson et al., 2012). “These patients had severe hypoxemia that was refractory to supplemental oxygen, but which in some cases was responsive to the application of positive end-expiratory pressure (PEEP)” (Ferguson et al., 2012, p. 1574). Autopsy also revealed widespread pulmonary inflammation, edema and hyaline membranes (Ferguson et al., 2012).
According to the American Lung Association, “Acute respiratory distress syndrome (ARDS) is a rapidly progressive disease occurring in critically ill patients.” ARDS is an extreme manifestation of a lung injury that can be associated with an acute medical problem. This occurs as a result of direct or indirect trauma to the lungs. With nearly 200,000 cases in the United States each year, ARDS is not extremely common (“Acute Respiratory Distress Syndrome”). Most people who acquire this disease are critically ill patients within the hospital. The most common predisposing medical problems of ARDS consist of: shock, trauma, pulmonary infections, sepsis, aspiration, and cardiopulmonary bypass (Ignatavicious, 2013). ARDS is a severe syndrome and even with prompt and aggressive medical treatment, almost fifty percent of those diagnosed do not survive. Those who survive have a longer hospital stay along with recurring hospital admissions throughout their lifetime (“Acute Respiratory Distress Syndrome”). Acute respiratory distress syndrome is a rapidly progressive disease which requires thorough assessment, rapid diagnosis, and emergency treatment measures in order to successfully respond to the disease process.
The coronavirus was first discovered in Jeddah, Saudi Arabia at the Dr. Soliman Fakeeh Hospital, when a patient with severe respiratory disease was failing to respond to any treatment or experience any sign of recovery. A sample of the sputum obtained by Dr. Ali Zaki was used to identify the virus. The virus found was unlike anything seen before. Dr. Ron Fouchier, at Erasmus Medical College in Rotterdam, Netherlands, identified the virus as a novel coronavirus, later called Middle East respiratory syndrome coronavirus.
Acute bronchitis is one of the most common diagnoses encountered in a primary care setting. It affects millions of individuals resulting in significant impact on health of patients and health care industry. Studies have shown that 90% of times acute bronchitis is caused by a virus, yet health care providers are failing to treat or manage these patients with appropriate therapies (Knutson & Braun, 2002). The focus of this paper is to review the guidelines for treatment of acute bronchitis after differentiating acute bronchitis from other common respiratory disease in terms of epidemiology, pathophysiology, clinical features, diagnosis, differential diagnosis, complications and patient education. Understanding the evaluation and treatment guidelines, nurse practitioners can provide evidence-based practice for patients with acute bronchitis.
In March 2003, the outbreak of Severe Acute Respiratory Syndrome (SARS), so far the most lethal infectious disease in this century, hit the world, including Taiwan. The unfortunate pandemic shattered Taiwan’s tourism industry and the nation’s image of a safe tourism destination region, thus affecting Taiwan’s economy. The Taiwanese government, as well as others that were affected, placed restrictions of varying stringency on domestic and international travel due to the cases of SARS. Therefore, precautions were taken and Taiwan’s global travel and tourism system deteriorated. Having Japan and Hong Kong as Taiwan’s two main sources of tourist arrivals, this pandemic decreased a huge amount of international arrivals from these generating
Respiratory distress syndrome (RDS) is a common lung disorder that mostly affects preterm infants. RDS is caused by insufficient surfactant production and structural immaturity of the lungs leading to alveolar collapse. Clinically, RDS presents soon after birth with tachypnea, nasal flaring, grunting, retractions, hypercapnia, and/or an oxygen need. The usual course is clinical worsening followed by recovery in 3 to 5 days as adequate surfactant production occurs. Research in the prevention and treatment of this disease has led to major improvements in the care of preterm infants with RDS and increased survival. However, RDS remains an important cause of morbidity and mortality especially in the most preterm infants. This chapter reviews the most current evidence-based management of RDS, including prevention, delivery room stabilization, respiratory management, and supportive care.
Severe Acute respiratory syndrome (SARS) is a respiratory illness that had recently been reported in Asia, North America, and Europe. SARS was first reported is Asia in February of 2003, over the next few months it spread to more than a dozen countries. By late July 2003, no new cases were being reported and the global outbreak was declared over by the World Health Organization. During this time period 8,098 people worldwide became infected with SARS and out of these 774 died. In the United States a total of 192 SARS cases had been reported, including 159 suspect and 33 probable cases. Of the probable only 8 had laboratory evidence of SARS-CoV infection. Luckily, no SARS relate deaths occurred in the US.
Back in April of 2012, a twenty-five year old man, who had recently traveled to parts of the Middle East, became ill in Saudi Arabia (WHO). He visited the hospital once he started seeing symptoms of an flu-like illness (WHO). To figure out what this virus was, doctor and researchers collected nasal sputum from individuals who were sick with what seemed like a new strain of the flu (WHO). This is when they discovered that the infectious agent of the illness was actually a coronavirus, which they called a novel coronavirus (CDPH). However, they renamed the coronavirus Middle East Respiratory Syndrome, also known as MERS-CoV (CDC). Prior to this occasion in 2012, it had never been seen in humans before, and it continued to spread from here (WHO). Symptoms of MERS-CoV include fever, cough, shortness or breath and difficulty breathing. (CDPH). This symptoms clearly explain why this coronavirus can be mistaken for a type of flu. Some patients may experience worse symptoms like gastrointestinal problems, diarrhea and kidney failure (WHO). Also, individuals who are infected but have weak immune systems may have an atypical presentation (WHO).